314 related articles for article (PubMed ID: 1660140)
21. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
[TBL] [Abstract][Full Text] [Related]
22. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
Börset M; Medvedev AE; Sundan A; Espevik T
Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
[TBL] [Abstract][Full Text] [Related]
23. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
Trentin L; Zambello R; Agostini C; Siviero F; Adami F; Marcolongo R; Raimondi R; Chisesi T; Pizzolo G; Semenzato G
Blood; 1993 Feb; 81(3):752-8. PubMed ID: 8381309
[TBL] [Abstract][Full Text] [Related]
24. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
Hui EK; Boado RJ; Pardridge WM
Mol Pharm; 2009; 6(5):1536-43. PubMed ID: 19624167
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells.
Ware CF; Crowe PD; Vanarsdale TL; Andrews JL; Grayson MH; Jerzy R; Smith CA; Goodwin RG
J Immunol; 1991 Dec; 147(12):4229-38. PubMed ID: 1661312
[TBL] [Abstract][Full Text] [Related]
27. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
Guo Z; Wang S; Jiao Q; Xu M; Xu Z
Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
[TBL] [Abstract][Full Text] [Related]
28. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.
Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P
Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827
[TBL] [Abstract][Full Text] [Related]
29. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
[TBL] [Abstract][Full Text] [Related]
30. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality.
Lesslauer W; Tabuchi H; Gentz R; Brockhaus M; Schlaeger EJ; Grau G; Piguet PF; Pointaire P; Vassalli P; Loetscher H
Eur J Immunol; 1991 Nov; 21(11):2883-6. PubMed ID: 1657617
[TBL] [Abstract][Full Text] [Related]
31. The mRNA expression patterns of tumor necrosis factor-alpha and TNFR-I in some vital organs after thermal injury.
Fang WH; Yao YM; Shi ZG; Yu Y; Wu Y; Lu LR; Sheng ZY
World J Gastroenterol; 2003 May; 9(5):1038-44. PubMed ID: 12717852
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.
Himmler A; Maurer-Fogy I; Krönke M; Scheurich P; Pfizenmaier K; Lantz M; Olsson I; Hauptmann R; Stratowa C; Adolf GR
DNA Cell Biol; 1990 Dec; 9(10):705-15. PubMed ID: 1702293
[TBL] [Abstract][Full Text] [Related]
33. Brain-penetrating tumor necrosis factor decoy receptor in the mouse.
Zhou QH; Boado RJ; Hui EK; Lu JZ; Pardridge WM
Drug Metab Dispos; 2011 Jan; 39(1):71-6. PubMed ID: 20884844
[TBL] [Abstract][Full Text] [Related]
34. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality.
Solorzano CC; Ksontini R; Pruitt JH; Auffenberg T; Tannahill C; Galardy RE; Schultz GP; MacKay SL; Copeland EM; Moldawer LL
Shock; 1997 Jun; 7(6):427-31. PubMed ID: 9185243
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
Dett CA; Gatanaga M; Ininns EK; Cappuccini F; Yamamoto RS; Granger GA; Gatanaga T
J Immunol; 1991 Mar; 146(5):1522-6. PubMed ID: 1847164
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.
Fiedler VB; Loof I; Sander E; Voehringer V; Galanos C; Fournel MA
J Lab Clin Med; 1992 Oct; 120(4):574-88. PubMed ID: 1402333
[TBL] [Abstract][Full Text] [Related]
37. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.
Peppel K; Crawford D; Beutler B
J Exp Med; 1991 Dec; 174(6):1483-9. PubMed ID: 1660525
[TBL] [Abstract][Full Text] [Related]
38. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
Espevik T; Brockhaus M; Loetscher H; Nonstad U; Shalaby R
J Exp Med; 1990 Feb; 171(2):415-26. PubMed ID: 1689365
[TBL] [Abstract][Full Text] [Related]
39. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA
Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064
[TBL] [Abstract][Full Text] [Related]
40. Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats.
Nys M; Damas J; Damas P; Laub R; Cloes JM; Lamy M
Med Microbiol Immunol; 1999 Nov; 188(2):55-64. PubMed ID: 10753056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
